MyEye brings life-changing tech to the visually impaired; Israeli biotech Redhill announced that the Phase 3 trial of its BEKINDA treatment for acute gastroenteritis and gastritis met its targets for efficacy and safety; Ariel University in Samaria recently held a ground-breaking ceremony for a new medical school, and much more.
ISRAEL’S MEDICAL ACHIEVEMENTS
Life-changing tech for the visually impaired
I reported previously (May 2016) on the text to speech MyEye device from Israeli startup Orcam. MyEye now clips onto your spectacles and can read text in English, Hebrew, Chinese, French, Italian and German. It can also store names and faces to help identify the people you meet.
Trials success for gastroenteritis treatment
Israeli biotech Redhill has announced that the Phase 3 trial of its BEKINDA treatment for acute gastroenteritis and gastritis, on 321 patients in 21 US clinical sites, met its targets for efficacy and safety. There are some 179 million cases of gastroenteritis annually in the US.
Israel’s new school of medicine
Ariel University recently held a ground-breaking ceremony for a new medical school. The $28 million facility will vastly enhance Ariel’s current pre-med program and 30 research labs. Currently, 4000 students are studying medicine at Israel’s five medical schools.
Fighting infections via DNA
I reported previously (July 2015) on Tel Aviv University Professor Udi Qimron’s research into bacterial viruses (phages) that can kill resistant bacteria. His DNA delivery method is now much more sophisticated and he has just received a $700,000 grant from TAU’s Momentum fund.
Algorithm finds new treatments
Professor Amiram Goldblum at the Hebrew University of Jerusalem has won a 2017 Kaye Innovation award for his Iterative Stochastic Elimination (ISE) algorithm, which helps discover new molecules to treat diseases. It identifies candidate treatments in months rather than years.
Making back to school less lousy
I reported previously (27th Nov) on Israeli startup Parasonic and its ultrasonic comb for destroying head lice and their eggs (nits). The device has now received FDA approval and should be launched by mid-2018. Parasonic has just raised $1.6 million of funds.
Games therapy for the brain
More about Israeli startup Intendu that I reported on previously (2nd July). Designed by neuroscientists, clinicians and games developers, the home training console is designed to enhance and possibly rehabilitate, eight cognitive functions. It is currently on trial at the UK’s Hull Royal Infirmary.
Israeli bio-techs in San Diego
23 Israeli companies (listed here) exhibited at the Bio International Convention in San Diego – the world’s largest conference in the field of life sciences, with over 16,000 delegates from some 76 countries.
What goes around, comes around
15 years ago, Batya donated a kidney to save her daughter’s life. Shortly afterwards, her daughter gave birth to a baby girl. 15 years later, Batya contracted Myelodysplastic syndrome (MDS) and needed a bone marrow transplant. Thanks to the Ezer Mizion database, a 100% match was found.
Click HERE for this week’s Good News from Israel.